drugset / Trial / NCT03708341

Exogenous Melatonin in Intensive Care Unit Chronodisruption

NCT03708341

Phase 3 Unknown 98 enrolled Saint-Joseph University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To this day, a small number of studies have evaluated the effect of melatonin on the modifications of the characteristics of sleep in critical care units, with mostly a small studied population. However, no study has been realized on a large population, nor has it evaluated the association between genetic factors and response to treatment (melatonin), hence the originality of our study. In our study we hypothesized that systematic melatonin usage in ICU can ameliorate the total sleep time and the fragmentation index and can decrease the confusion related to sleep deprivation.

Timeline

Start
2018-11-15
Primary completion
2024-03-01
Completion
2024-03-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 5 mg

Indications